Mario Manto Selected Research

Ataxia (Dyssynergia)

1/2022	Pharmacotherapy of cerebellar and vestibular disorders.
1/2021	Identification of the Prodromal Symptoms and Pre-Ataxic Stage in Cerebellar Disorders: The Next Challenge.
1/2021	Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.
8/2020	Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.
8/2020	Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia-Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias.
1/2019	The Era of Cerebellar Therapy.
1/2019	Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
8/2018	Time Is Cerebellum.
1/2018	Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia.
1/2017	Immune-mediated cerebellar ataxias: from bench to bedside.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Manto Research Topics

Disease

25	Cerebellar Ataxia (Dysmetria) 04/2022 - 01/2008
15	Ataxia (Dyssynergia) 01/2022 - 08/2009
10	Cerebellar Diseases (Cerebellar Syndrome) 06/2019 - 09/2009
5	Tremor (Tremors) 01/2014 - 01/2007
4	Stroke (Strokes) 12/2022 - 01/2017
4	Movement Disorders (Movement Disorder) 12/2022 - 04/2007
4	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021 - 01/2019
3	Nervous System Diseases (Neurological Disorders) 06/2022 - 01/2015
3	Friedreich Ataxia (Friedreich's Ataxia) 01/2022 - 04/2010
3	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021 - 01/2015
3	Paraneoplastic Cerebellar Degeneration 01/2021 - 04/2016
3	Stiff-Person Syndrome (Stiff Man Syndrome) 10/2018 - 06/2013
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 10/2016 - 06/2009
3	Encephalitis (Encephalitis, Rasmussen) 06/2016 - 11/2010
3	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 10/2013 - 08/2009
2	Multiple Sclerosis 01/2022 - 08/2018
2	Type 2 Episodic Ataxia 01/2022 - 04/2020
2	Disease Progression 12/2019 - 01/2017
2	Neoplasms (Cancer) 01/2019 - 01/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018 - 01/2015
2	Essential Tremor (Essential Tremors) 06/2016 - 04/2007
1	Benign Paroxysmal Positional Vertigo 01/2022
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Meniere Disease (Menieres Disease) 01/2022
1	Fetal Alcohol Spectrum Disorders 01/2021
1	Thiamine Deficiency 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Infections 08/2020
1	Autoimmune Diseases (Autoimmune Disease) 08/2020
1	Cytokine Release Syndrome 08/2020
1	Leukocytosis (Pleocytosis) 08/2020
1	Inflammation (Inflammations) 01/2020
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2020
1	Leukoencephalopathies 01/2019
1	Adenocarcinoma 01/2019
1	Brain Diseases (Brain Disorder) 12/2018
1	Epilepsy (Aura) 10/2018
1	Wounds and Injuries (Trauma) 08/2018
1	Hydrocephalus (Hydrocephaly) 01/2018

Drug/Important Bio-Agent (IBA)

11	AntibodiesIBA 02/2022 - 11/2010
6	Glutens (Glutelin)IBA 01/2022 - 04/2016
6	AutoantibodiesIBA 07/2020 - 06/2013
5	EpitopesIBA 10/2018 - 06/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2020
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2009
3	Protein Isoforms (Isoforms)IBA 10/2018 - 06/2013
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 10/2018 - 01/2015
3	N-Methylaspartate (NMDA)IBA 06/2016 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 08/2020
2	metabotropic glutamate receptor type 1IBA 02/2022 - 01/2021
2	Glutamate Receptors (Glutamate Receptor)IBA 02/2022 - 01/2021
2	Carboxy-LyasesIBA 01/2022 - 01/2019
2	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2022 - 04/2020
2	Ion Channels (Ion Channel)IBA 01/2021 - 07/2020
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 04/2020 - 01/2012
2	AntioxidantsIBA 01/2019 - 04/2010
2	salicylhydroxamic acid (SHAM)IBA 12/2018 - 01/2014
2	EnzymesIBA 10/2018 - 04/2010
2	Heroin (Diamorphine)IBA 01/2018 - 01/2012
2	LithiumIBA 01/2018 - 01/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 01/2012
2	SaltsIBA 01/2018 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 10/2013
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2011 - 11/2010
1	Complement System Proteins (Complement)IBA 06/2022
1	Betahistine (Serc)IBA 01/2022
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2022
1	SteroidsIBA 01/2022
1	AcidsIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	acetylleucineIBA 01/2022
1	omaveloxoloneIBA 01/2022
1	Oligoclonal BandsIBA 08/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2020
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 07/2020
1	Biological ProductsIBA 01/2020
1	AminopyridinesIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Leucovorin (Folinic Acid)FDA Link 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	AntigensIBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	anti-GAD65 autoantibodyIBA 10/2018

Therapy/Procedure

16	Therapeutics 06/2022 - 04/2007
6	Transcranial Direct Current Stimulation 12/2022 - 01/2008
3	Orthotic Devices (Orthosis) 06/2015 - 01/2007
2	Gluten-Free Diet 01/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2013
2	Injections 11/2017 - 06/2016
2	Brain-Computer Interfaces 01/2013 - 01/2010
1	Endovascular Procedures 06/2021
1	Operative Surgical Procedures 06/2021
1	Thrombectomy 06/2021
1	Craniotomy 06/2021
1	Occupational Therapy (Therapy, Occupational) 04/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2019
1	Transplantation 06/2019